Michael D. Clayman's Net Worth
$2.4 Million
Who is Michael D. Clayman?
Michael D. Clayman has an estimated net worth of $2.4 Million. This is based on reported shares across multiple companies, which include Flexion Therapeutics Inc, and Akebia Therapeutics, Inc..
SEC CIK
Michael D. Clayman's CIK is 0001597407
Past Insider Trading and Trends
2016 was Michael D. Clayman's most active year for acquiring shares with 14 total transactions. Michael D. Clayman's most active month to acquire stocks was the month of May. 2021 was Michael D. Clayman's most active year for disposing of shares, totalling 15 transactions. Michael D. Clayman's most active month to dispose stocks was the month of October. 2018 saw Michael D. Clayman paying a total of $320,532.38 for 188,688 shares, this is the most they've acquired in one year. In 2021 Michael D. Clayman cashed out on 1,860,821 shares for a total of $2,960,292.12, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Flexion Therapeutics Inc No price found
President and CEOMichael D. Clayman used to own units in Common Stock but no longer holds any shares there. In the year 2014 Michael D. Clayman filed a total of 49 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -1.12M |
$8.50 | -$9,541,675.00 |
0
|
Nov 19
| |||
Form 4
| -3.97% | -13.86K |
—
|
—
| 334.98K |
Jul 19
| |||
Form 4
| +0.49% | 1.7K |
$7.78 | $13,226.00 | 348.84K |
Jun 21
| |||
Form 4
| -6.93% | -25.86K |
—
|
—
| 347.14K |
Jan 8 - Feb 1
| |||
Form 4
| +39.75% | 106.1K |
—
|
—
| 373K |
Mar 1
| |||
Form 4
| +70.90% | 110.72K |
$12.37 | -$108,559.12 | 266.9K |
Jan 27 - Jan 28
| |||
Form 4
| -2.40% | -3.83K |
—
|
—
| 156.18K |
Jul 8 - Jan 5
| |||
Form 4
| +141.49% | 93.75K |
—
|
—
| 160.01K |
Jul 16
| |||
Form 4
| +2.01% | 1.3K |
$10.83 | $14,111.49 | 66.26K |
Jun 22
| |||
Form 4
| +3.05% | 10.26K |
$9.75 | $99,996.00 | 346.61K |
May 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 2
| |||
Form 4
| -2.82% | -13.41K |
—
|
—
| 473.56K |
Oct 9 - Jan 7
| |||
Form 4
| +14.39% | 10.4K |
$13.98 | -$61,539.96 | 82.65K |
Oct 6 - Oct 7
| |||
Form 4
| +3.31% | 2.32K |
$10.85 | $25,136.21 | 72.25K |
Aug 8
| |||
Form 4
| +0.38% | 1.49K |
$9.81 | $14,636.52 | 390.43K |
Jan 28 - Jun 24
| |||
Form 4
| +5.66% | 4.01K |
$12.48 | $50,067.35 | 74.87K |
May 10
| |||
Form 4
| +6.06% | 4.05K |
$12.36 | $50,008.56 | 70.86K |
Mar 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
| -4.68% | -3.28K |
$12.36 | -$40,516.08 | 66.81K |
Scheduled
|
Jan 3
| ||
Form 4
| +1.32% | 5K |
$17.10 | $85,476.50 | 383.23K |
Feb 27 - Nov 9
| |||
Form 4
| +11.38% | 8.57K |
$18.60 | -$115,933.80 | 83.85K |
Oct 8
| |||
Form 4
| +15.32% | 10K |
$22.33 | $223,300.00 | 75.28K |
Aug 9
| |||
Form 4
| +0.86% | 554 |
$21.22 | $11,755.88 | 65.28K |
Jun 20
| |||
Form 4
| +82.02% | 29.17K |
—
|
—
| 64.73K |
Feb 1
| |||
Form 4
| +0.47% | 166 |
$16.59 | $2,753.94 | 35.56K |
Dec 20
| |||
Form 4
| +16.45% | 5K |
$23.60 | $118,000.00 | 35.4K |
Nov 8
| |||
Form 4
| +42.11% | 9.01K |
$29.93 | -$173,442.81 | 30.39K |
Oct 6
| |||
Form 4
| +6.17% | 1.24K |
$15.37 | $19,104.91 | 21.39K |
Jun 20
| |||
Form 4
| +33.01% | 5K |
$17.23 | $86,151.50 | 20.15K |
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
| 309.53K |
Jun 21
| |||
Form 4
| +0.48% | 147 |
$9.01 | $1,324.47 | 30.87K |
Dec 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 20
| |||
Form 4
| +5.74% | 1.67K |
$18.41 | $30,688.30 | 30.72K |
Nov 23
| |||
Form 4
| +6.08% | 1.67K |
$17.95 | $29,900.20 | 29.05K |
Nov 22
| |||
Form 4
| +6.48% | 1.67K |
$17.90 | $29,827.40 | 27.39K |
Nov 21
| |||
Form 4
| +67.54% | 10.37K |
$0.16 | $1,686.00 | 25.72K |
May 23
| |||
Form 4
| +17.29% | 2K |
$10.41 | $20,810.40 | 13.57K |
May 20
| |||
Form 4
| +20.90% | 2K |
$9.65 | $19,297.20 | 11.57K |
May 19
| |||
Form 4
| +26.43% | 2K |
$10.23 | $20,465.00 | 9.57K |
May 18
| |||
Form 4
| +35.92% | 2K |
$9.73 | $19,465.00 | 7.57K |
May 17
| |||
Form 4
| +56.05% | 2K |
$9.51 | $19,025.00 | 5.57K |
May 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
| +0.64% | 1.78K |
$11.91 | $21,247.44 | 282.23K |
May 20
| |||
Form 4
| +1.82% | 5K |
$0.16 | $813.00 | 280.44K |
Mar 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 21
| |||
Form 4
| +0.65% | 1.78K |
$11.91 | $21,247.44 | 275.44K |
Nov 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 3
| |||
Form 4
| +1,115.39% | 356.7K |
—
|
—
| 388.68K |
Feb 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Akebia Therapeutics, Inc. (AKBA) Snapshot price: $1.36
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||